In a 55‑year‑old man with a recent electrocardiogram showing sinus rhythm, a QS complex in V1, poor R‑wave progression in V2, left‑atrial enlargement, and a prolonged QT interval, what is the most likely diagnosis and appropriate treatment?

Differential Diagnosis and Management of ECG Findings in a 55-Year-Old Male

Most Likely Diagnosis

The ECG pattern of QS complex in V1, poor R-wave progression in V2, left atrial enlargement, and prolonged QT interval most likely represents either prior anterior myocardial infarction with left atrial enlargement or acquired long QT syndrome (aLQTS) with underlying structural heart disease—not congenital long QT syndrome given the age of presentation.

Diagnostic Approach

QS Complex and Poor R-Wave Progression

• QS deflections in V1-V2 without other ECG abnormalities are frequently misdiagnosed as septal infarction, but retrospective analysis shows this pattern represents prior myocardial infarction in only a minority of cases (approximately 20%), and isolated septal infarction is exceptional. 1

• This ECG finding should be interpreted as a nonspecific QRS abnormality with multiple possible causes, including improper lead placement (the most common cause when intermittent on serial ECGs), prior anterior wall infarction, left ventricular hypertrophy, or cardiomyopathy. 1

• Clinical correlation with cardiac imaging (echocardiography) is essential to determine if there is regional wall motion abnormality suggesting prior infarction, left ventricular dysfunction, or structural heart disease. 1

Left Atrial Enlargement

• Left atrial enlargement in this context suggests chronic pressure or volume overload, commonly from hypertension, valvular disease (especially mitral), or left ventricular dysfunction. 2

• This finding increases the risk of atrial fibrillation and should prompt evaluation for underlying causes of left atrial dilation. 2

Prolonged QT Interval

The QT interval must first be properly measured and corrected for heart rate (QTc):

• Measure from the onset of QRS to where the tangent of the T-wave downslope intersects the baseline, using lead II or V5. 3

• Upper normal QTc is <450 ms in men and <460 ms in women; QTc ≥480 ms is definitely abnormal, and QTc ≥500 ms significantly increases torsades de pointes risk. 3

At age 55 with new ECG findings, this is almost certainly acquired long QT syndrome (aLQTS) rather than congenital:

• Congenital LQTS (cLQTS) typically presents earlier in life with syncope during exercise, swimming, or loud noises, or with family history of sudden death. 3

• aLQTS results from QT-prolonging medications, electrolyte abnormalities (hypokalemia, hypomagnesemia, hypocalcemia), or structural heart disease. 3

Immediate Management Steps

1. Identify and Address Reversible Causes of QT Prolongation

Medication review is paramount:

• Review ALL current medications using www.crediblemeds.org to identify QT-prolonging drugs, including "antidrugs" (antibiotics like fluoroquinolones and macrolides, antipsychotics, antidepressants like citalopram, antiemetics, and analgesics). 3

• Discontinue any QT-prolonging medications immediately if QTc ≥500 ms; if QTc <500 ms with no syncope history, consider continuation with close monitoring only if the drug is essential. 3

• Common culprits include citalopram and escitalopram (high-risk SSRIs), ciprofloxacin and erythromycin (high-risk antibiotics), while sertraline, azithromycin, cephalosporins, and penicillins carry minimal to no risk. 3

Electrolyte correction:

• Check and aggressively correct potassium (goal >4.0 mEq/L), magnesium (goal >2.0 mg/dL), and calcium levels. 3

• Electrolyte abnormalities are a leading cause of aLQTS and must be normalized before attributing QT prolongation to other causes. 3

2. Cardiac Evaluation for Structural Disease

Given the combination of QS complex, poor R-wave progression, and left atrial enlargement:

• Obtain transthoracic echocardiography urgently to assess for:

  • Regional wall motion abnormalities (prior infarction)
  • Left ventricular systolic function
  • Left atrial size quantification
  • Valvular disease
  • Left ventricular hypertrophy 1

• Consider cardiac biomarkers (troponin) and coronary evaluation if there is clinical suspicion for acute coronary syndrome or if echocardiography reveals regional wall motion abnormalities suggesting ischemic heart disease. 1

3. Risk Stratification for Arrhythmia

If QTc remains ≥500 ms after addressing medications and electrolytes:

• This patient is at high risk for torsades de pointes (TdP) and requires continuous cardiac monitoring. 3

• Avoid amiodarone and procainamide, which further prolong QT and are contraindicated in LQTS-related arrhythmias. 3

• If TdP occurs, treat with intravenous magnesium (even if serum levels are normal), correction of bradycardia, and cessation of all QT-prolonging drugs. 3

4. Consideration of Congenital LQTS (Less Likely but Must Exclude)

Although age 55 makes cLQTS less likely, consider if:

• History of unexplained syncope, especially with exercise, swimming, or loud noises. 3

• Family history of sudden unexplained death or known LQTS. 3

• QTc remains prolonged (>480 ms) after eliminating all acquired causes. 3

If cLQTS is suspected:

• Refer to an inherited arrhythmia clinic (in Canada: www.heartsinrhythm.ca; internationally: www.sads.org). 3

• Exercise testing may reveal abnormal QTc prolongation in recovery (especially at 4 minutes post-exercise), which is characteristic of cLQTS. 3

• Genetic testing for LQTS types 1-3 (most common autosomal dominant forms) may be indicated, but clinical phenotyping takes precedence. 3

Definitive Treatment Based on Etiology

If Acquired Long QT Syndrome (Most Likely)

Primary treatment is elimination of the underlying cause:

• Permanent discontinuation of QT-prolonging medications with substitution of safer alternatives (e.g., sertraline instead of citalopram for depression, azithromycin instead of ciprofloxacin for infections). 3

• Maintenance of normal electrolytes indefinitely, with regular monitoring if the patient has conditions predisposing to electrolyte disturbances (diuretic use, diarrhea, malnutrition). 3

• Beta-blockers are NOT routinely indicated for aLQTS unless there is concurrent indication (e.g., heart failure, coronary disease). 3

If Congenital Long QT Syndrome (Unlikely but Possible)

If cLQTS is confirmed after excluding acquired causes:

• Nadolol is the beta-blocker of choice for high-risk patients (QTc ≥500 ms, prior syncope, or cardiac arrest), dosed at 1-1.5 mg/kg once daily. 3

• Bisoprolol may be used for lower-risk patients (QTc <500 ms, no prior events) as it is better tolerated with rare breakthrough events. 3

• Lifelong avoidance of QT-prolonging medications is imperative, even with beta-blocker therapy, as medication non-compliance and QT-prolonging drug exposure are the primary causes of breakthrough cardiac events. 3

If Structural Heart Disease is Present

Management depends on echocardiographic findings:

• If prior myocardial infarction with reduced ejection fraction: guideline-directed medical therapy for heart failure and consideration of implantable cardioverter-defibrillator (ICD) if ejection fraction ≤35%. 1

• If left atrial enlargement from hypertension or valvular disease: treat the underlying cause and consider anticoagulation if atrial fibrillation develops. 2

Critical Pitfalls to Avoid

• Do not assume QS complexes in V1-V2 represent septal infarction without imaging confirmation—this is a common misdiagnosis. 1

• Do not overlook medication-induced QT prolongation—many commonly prescribed drugs (antidepressants, antibiotics, antiemetics) prolong QT. 3

• Do not use amiodarone or procainamide for ventricular arrhythmias in the setting of prolonged QT—these agents worsen QT prolongation and increase TdP risk. 3

• Do not diagnose cLQTS without excluding all acquired causes first—at age 55, aLQTS is far more likely. 3

• Do not forget to recheck ECG after medication washout and electrolyte correction—if QTc normalizes, the diagnosis is aLQTS and no further cardiac genetic evaluation is needed. 3